Akermin, established in 2004 in St. Louis, Missouri, is "Pioneering Next-Gen Biofuel Cells and Enzyme Applications for Diverse Industries" as per their slogan. The company's main focus is on commercial applications in wireless sensors and military uses, utilizing innovative stabilized enzyme technology created at Saint Louis University. Akermin showcased a prototype biofuel cell by 2008 that operates on methanol fuel and uses stabilized laccase as a replacement for the metal catalyst in traditional cathodes. The development of stabilized enzymes for use in the food processing, biofuels, chemical, and pharmaceutical industries is also underway. The company operates within the Biotechnology, Health Care, IT, Manufacturing, Autonomous, and Sensor Tech industries. Akermin received a $3.00M grant investment on 21 October 2013. The investors for this last investment are currently undisclosed.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | $3.00M | - | 21 Oct 2013 | |
Debt Financing | $1.30M | - | 08 Aug 2013 | |
Venture Round | $1.50M | 3 | 19 Feb 2013 | |
Venture Round | $4.08M | - | 05 Jan 2011 | |
Series B | $10.00M | 5 | Emerson Ventures | 26 Jan 2010 |
No recent news or press coverage available for Akermin.